Abstract
CRISP is a non-interventional, prospective, multi-center clinical research platform to understand the treatment reality of patients (pts) with lung cancer in Germany. Locally advanced non-small cell lung cancer (NSCLC) is a heterogenous group with several treatment approaches possible. Here we present data of pts treated with radiochemotherapy (RTCTx) in routine care in Germany.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have